Community/Retail

The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.

Latest News

Next-generation sequencing | Image Credit: © Supaporn - stock.adobe.com
Biomarker Testing Transforms NSCLC Care, But Gaps Persist in Community Settings

April 30th 2025

Biomarker testing transforms non-small cell lung cancer treatment, enhancing outcomes through targeted therapies and next-generation sequencing for better patient care.

National Stress Awareness Month Is Here
National Stress Awareness Month Is Here

April 30th 2025

Assuring clients are informed. Shot of a young pharmacist helping an elderly customer at the prescription counter.
Asembia AXS25: Pharmacists Continue to Expand Clinical, Collaborative Role in Health Care

April 29th 2025

Blue FDA approval stamp -- Image credit: B-design | stock.adobe.com
FDA Approves Upadacitinib for Adult Patients With Giant Cell Arteritis

April 29th 2025

More News


Site Logo

Pharmacy Advocates Deliver Change

March 25th 2010

In more than 200 face-to-face meetings with the nation's most influential agents of health care reform, representatives of the National Association of Chain Drug Stores relayed a clear, united message about the value of pharmacy at this year����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½������¯����¯�¿�½������¿����¯�¿�½������½����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������¢����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������¯����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������¿����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������½����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������¯����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������¿����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������½s RxIMPACT Day, held March 10 and 11.

Read More


Site Logo

Cold/Flu Podcast #5

February 23rd 2010

Covering key finding #5 - Efficacy is the most important consideration for pharmacists providing counsel about OTC cold and flu products; oral zinc-based remedies found most effective in shortening the duration of a cold The final audio podcast is now available at www.pharmacytimes.com/cold-and-flu and www.Zicam.com. The survey showed 66 percent of pharmacists who feel treating early is very important are more likely to rate oral zinc-based remedies as effective at quickly shortening a cold’s duration; however, despite the fact that oral zinc-based remedies are seen as more effective to shorten the duration of a cold, 53 percent of pharmacists are most likely to recommend multi-symptom relief products to help patients who come in at the first sign of symptoms get over their cold faster. Dr. Eckel and the roundtable discussed how there are a lot of misperceptions with multi-symptoms products; however, because patients rarely seek treatment at first signs, pharmacists are going to recommend what they need at the stage of their illness. Discussion also included: The importance of efficacy messages relating to patient consultation. The need for product samples as well as interpretable studies that show the safety/efficacy of a product. The need for information regarding correct delivery of oral zinc-based products. We hope you have found this podcast series educational and informative. If you would like more information about the Pharmacist O.T.C. survey, the role of the pharmacist, helping patients treat their colds earlier and oral zinc based products, please visit www.pharmacytimes.com/cold-and-flu or www.Zicam.com.

Read More